Learn how to catch pharmacy labeling errors before taking your medication. Know what to check on the label, spot dangerous drug name mix-ups, and use simple steps to prevent life-threatening mistakes.
Authorized generics are identical to brand-name drugs but sold without the brand label. They offer the same effectiveness with lower cost-perfect for patients who need consistency. Here's how they work, why they exist, and when to choose them.
Visual dosing aids like syringes, droppers, and measuring cups reduce medication errors by making doses easy to see and measure. Used in homes and hospitals, they save lives by eliminating guesswork in liquid medicine administration.
Learn how dissolution profiles are used to prove generic drugs work like brand-name versions. Understand the f2 factor, regulatory standards, and why this test saves time and money without compromising safety.
Transcription errors in e-prescribing systems are causing preventable medication mistakes. Learn the 6 proven strategies to stop them-standardized sigs, CancelRx, FHIR integration, and more-backed by real data from U.S. clinics and pharmacies.
The FDA ensures generic drug quality through strict cGMP standards, unannounced inspections, and rigorous testing. Every generic drug must match the brand-name version in safety, strength, and effectiveness - not by luck, but by design.
Hospital pharmacies are bearing the brunt of a growing crisis: sterile injectable drug shortages. With 226 active shortages in mid-2025, critical medications like anesthetics and chemotherapy drugs are vanishing - forcing staff to make impossible choices and delay life-saving treatments.
Rhabdomyolysis from medication interactions is a silent threat - often missed until kidneys fail. Statins, antibiotics, and common combos can trigger muscle breakdown. Know the signs, ask the right questions, and protect yourself.
The first generic drug to hit the market after a patent expires captures up to 80% of sales during its 180-day exclusivity window-and often keeps 30-40% long after. Here’s why being first matters more than price.
Paragraph IV certifications let generic drug makers legally challenge brand-name drug patents before they expire. This Hatch-Waxman Act mechanism triggers lawsuits, grants 180-day exclusivity to winners, and has saved U.S. consumers over $1.7 trillion since 1984.